Latest News

California legislators must prioritize patients over profits

In the battle against chronic diseases, patients face an unexpected adversary: 'copay accumulators' jeopardizing access to life-saving medications, forcing impossible choices between health and sustenance. CRA President, Samy Metyas, MD shares his opinion and urges CA...

CRA Diamond Member News: Pfizer Study Recruitment

Pfizer’s Myositis Research Do you have patients with Dermatomyositis or Polymyositis who may be eligible to participate in an ongoing Phase 3 clinical research study?  • This study is currently recruiting in 9 states in the USA and will add additional sites...

What Happens When COVID-19 Collides With Flu Season?

What Happens When COVID-19 Collides With Flu Season?

Many questions remain about how flu season might affect the pandemic, and vice versa. For example, would coinfection with influenza worsen the course of COVID-19? Experts also aren’t certain whether influenza vaccination could help protect against COVID-19 or whether...

ANTHEM’S SPECIALTY PHARMACY MANDATE

It was brought to the CRA’s attention that Anthem Blue Cross recently notified physicians that effective December 1, 2020, it will expand its specialty medication policy to also apply to its commercial PPO and EPO plans. This new PPO policy, which goes into effect for...

CRA Press Release – October 29, 2020 re: Anthem SPP Mandate

The CRA issued a press release today outlining the dangerous policy change Anthem plans to implement for PPO and EPO subscribers. We have sent a letter to Beth Andersen, Anthem’s California Plan President requesting a meeting and reconsideration of a proposed policy...

CRA Diamond Member News: Pfizer Medical Portal Open

The new Pfizer Medical portal is now live The new Pfizer Medical portal is a personalized digital experience that easily connects you to cross-therapeutic Pfizer medical content and experts—all in one place. Explore these resources at pfizermedical.pfizerpro.com....

CRA Diamond Member News: AS: Lessons from HCP Journeys

AS Diagnosis: Lessons from Two Rheumatologists’ Journeys With approximately 3 out of every 1000 people in North America living with ankylosing spondylitis (AS), based on a 2013 prevalence study, properly targeted care and diagnoses are key. Watch these videos to learn...

CRA Diamond Member News: Abbvie Ankylosing Spondylitis resource

At AbbVie, we are committed to providing treatment options for patients with ankylosing spondylitis (AS). To learn more about a treatment option for your adult patients with active AS, please visit: https://abbv.ie/rv-aspdc. ©2022 Abbvie Ltd. All rights reserved....